Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Targeted Nanoparticles Map Tumor Blood Supply in 3-D, Assess Therapy

Abstract:
One of the defining characteristics of solid tumors is the development of a network of new blood vessels to nourish the rapidly reproducing malignant cells. Now, using a nanoparticle targeted to those new blood vessels, a joint academic-industrial research team, led by investigators from the Siteman Center of Cancer Nanotechnology Excellence, has developed a way to construct a three-dimensional (3-D) map of tumor-induced angiogenesis and monitor the effects of drug therapies on those new blood vessels.

Targeted Nanoparticles Map Tumor Blood Supply in 3-D, Assess Therapy

Bethesda , MD | Posted on September 27th, 2008

Reporting its work in the FASEB Journal, a research team headed by Washington University in St. Louis colleagues Gregory Lanza, M.D., and Samuel Wickline, M.D., described its development of a perfluorinated nanoparticle loaded with gadolinium ions, which boost magnetic resonance imaging (MRI) signals, and then coating this nanoparticle with a peptide that targets new blood vessels. This particular peptide binds strongly to a cell-surface protein known as a5b1 integrin. For the sake of comparison, the investigators also prepared an identical nanoparticle but coated it with a related peptide that does not bind to a5b1 integrin. They also prepared a third nanoparticle coated with a small organic molecule that binds to both a5b1 integrin and avb3 integrin.

When the investigators injected the nanoparticle targeted to a5b1 integrin into tumor-bearing mice, they were able to use MRI to produce a 3-D map of tumor-associated blood vessels. From this map, the researchers were able to show that nearly all of the new blood vessels were on the rim of the tumor. The investigators confirmed these findings through microscopic examination of the tumors after they had been removed surgically from the mice.

Next, the investigators injected the mice with nanoparticles loaded with a drug known as fumigillin, which stops new blood vessel growth. Some of these nanoparticles were coated with the a5b1 integrin targeting peptide, whereas others were coated with the small organic molecule that binds to both a5b1 integrin and avb3 integrin. They then used the MRI-enhancing nanoparticle that targeted a5b1 integrin and avb3 integrin to assess any therapeutic changes produced by the fumagillin-loaded nanoparticles. The resulting 3-D images showed that the dual-targeted, drug-loaded nanoparticle decreased tumor-associated angiogenesis to near neglible levels. The singly targeted nanoparticles were less effective, and the untargeted nanoparticle was ineffective at reducing angiogenesis.

Somewhat surprisingly, the reduction in angiogenesis did not have an effect on tumor size. The researchers attributed this observation to the fact that the tumor model they used does not produce as much angiogenesis as do other more common models of human cancer. The researchers chose this model because they wanted to determine whether their nanoparticles could image relatively sparse angiogenesis, a normally difficult proposition.

####

About National Cancer Institute
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

Copyright © National Cancer Institute

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

View Abstract - “In Vivo Tumor Cell Targeting With ‘Click’ Nanoparticles.”

Related News Press

News and information

Silicene Labs Announces the Launch of Patent-Pending, 2D Materials Composite Index™ : The Initial 2D Materials Composite Index™ for Q2 2014 Is: 857.3; Founders Include World-Renowned Physicist and Seasoned Business and IP Professionals July 24th, 2014

Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Imaging

EPFL Research on the use of AFM based nanoscale IR spectroscopy for the study of single amyloid molecules wins poster competition at Swiss Physics Society meeting July 22nd, 2014

Bruker Awarded Fourth PeakForce Tapping Patent: AFM Mode Uniquely Combines Highest Resolution Imaging and Material Property Mapping July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

"Nanocamera" takes pictures at distances smaller than light's own wavelength: How is it possible to record optically encoded information for distances smaller than the wavelength of light? July 17th, 2014

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Discoveries

Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Nano-sized Chip "Sniffs Out" Explosives Far Better than Trained Dogs: TAU researcher's groundbreaking sensor detects miniscule concentrations of hazardous materials in the air July 23rd, 2014

Announcements

Silicene Labs Announces the Launch of Patent-Pending, 2D Materials Composite Index™ : The Initial 2D Materials Composite Index™ for Q2 2014 Is: 857.3; Founders Include World-Renowned Physicist and Seasoned Business and IP Professionals July 24th, 2014

Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE